Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 9Unknown 6Recruiting 5Not yet recruiting 3Active not recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Myelodysplastic Syndromes 1Motor Activity 1Leukemia, Myeloid, Acute 1

Interventions

pembrolizumab 436Carboplatin 321Nivolumab 287Cyclophosphamide 280Specimen Handling 257Cisplatin 251Paclitaxel 248Magnetic Resonance Spectroscopy 248Radiotherapy 217Gemcitabine 180Dexamethasone 180Biopsy 177durvalumab 166atezolizumab 148Rituximab 138Lenalidomide 134Doxorubicin 134Docetaxel 130Bevacizumab 129Ipilimumab 125Radiation 118Capecitabine 117Pemetrexed 112Oxaliplatin 112Etoposide 111Radiosurgery 108Fluorouracil 108venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Rehabilitation × Clear all
NCT06238596 2025-10-03

ReCaP

Azienda USL Reggio Emilia - IRCCS

Phase NA Active not recruiting
38 enrolled
Genitourinary

Prostatic Neoplasms

NCT03595787 2024-12-18

COHABILIT

Institut Paoli-Calmettes

Phase NA Active not recruiting
50 enrolled
MyeloidOther hematologic neoplasm

Motor Activity, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡